Merz Group

Merz Pharmaceuticals is an innovative pharmaceutical company specializing in the research and marketing of drugs for the treatment of neurological and psychiatric disorders. Merz is a leader in Alzheimer's disease research and developed the world’s first drug for the treatment of moderate to severe Alzheimer’s disease. In the field of neurology, Merz also offers medications for the treatment of Parkinson’s disease, depression, and dystonia.